Back to tickers

Intellia Therapeutics, Inc. (NTLA)

Nasdaq · CIK 0001652130

Form Report Date Filing Date Description
8-K 2026-09-08 2026-09-08 8-K
8-K 2026-09-04 2026-09-04 8-K
10-Q 2026-06-30 2026-08-06 10-Q
8-K 2026-08-06 2026-08-06 8-K
8-K 2026-06-13 2026-06-15 8-K
8-K 2026-06-09 2026-06-10 8-K
10-Q 2026-03-31 2026-05-11 10-Q
8-K 2026-05-11 2026-05-11 8-K
8-K 2026-04-27 2026-04-30 8-K
8-K 2026-04-27 2026-04-27 8-K
8-K 2026-04-07 2026-04-10 8-K
8-K 2026-03-02 2026-03-02 8-K
10-K 2025-12-31 2026-02-26 10-K
8-K 2026-02-26 2026-02-26 8-K
8-K 2026-01-27 2026-01-27 8-K
8-K 2026-01-09 2026-01-09 8-K
8-K 2025-11-08 2025-11-10 8-K
10-Q 2025-09-30 2025-11-06 10-Q
8-K 2025-11-06 2025-11-06 8-K
8-K 2025-10-29 2025-10-29 8-K
8-K 2025-10-27 2025-10-27 8-K
8-K 2025-09-25 2025-09-25 8-K
8-K 2025-08-07 2025-08-07 8-K
10-Q 2025-06-30 2025-08-07 10-Q
8-K 2025-06-15 2025-06-16 8-K
8-K 2025-06-11 2025-06-12 8-K
8-K 2025-05-28 2025-05-28 8-K
8-K 2025-05-18 2025-05-19 8-K
8-K 2025-05-08 2025-05-08 8-K
10-Q 2025-03-31 2025-05-08 10-Q
8-K 2025-04-03 2025-04-07 8-K
8-K 2025-02-27 2025-02-27 8-K
10-K 2024-12-31 2025-02-27 10-K
8-K 2025-02-18 2025-02-21 8-K
8-K 2025-01-09 2025-01-10 8-K
8-K 2024-11-16 2024-11-18 8-K
8-K 2024-11-07 2024-11-07 8-K
10-Q 2024-09-30 2024-11-07 10-Q
8-K 2024-10-24 2024-10-25 8-K
10-Q 2024-06-30 2024-08-08 10-Q
8-K 2024-08-08 2024-08-08 8-K
8-K 2024-06-21 2024-06-26 8-K
8-K 2024-06-12 2024-06-14 8-K
8-K 2024-06-12 2024-06-13 8-K
8-K 2024-05-09 2024-05-09 8-K
10-Q 2024-03-31 2024-05-09 10-Q
8-K 2024-04-10 2024-04-15 8-K
8-K 2024-03-19 2024-03-22 8-K
8-K 2024-02-23 2024-02-23 8-K
8-K 2024-02-22 2024-02-22 8-K
10-K 2023-12-31 2024-02-22 10-K
8-K 2024-01-31 2024-02-01 8-K
8-K 2024-01-04 2024-01-04 8-K
8-K 2023-12-05 2023-12-06 8-K
10-Q 2023-09-30 2023-11-09 10-Q
8-K 2023-11-09 2023-11-09 8-K
8-K 2023-11-02 2023-11-02 8-K
8-K 2023-10-18 2023-10-18 8-K
8-K 2023-10-03 2023-10-03 8-K
8-K 2023-08-03 2023-08-03 8-K
10-Q 2023-06-30 2023-08-03 10-Q
8-K 2023-06-14 2023-06-16 8-K
8-K 2023-06-11 2023-06-12 8-K
8-K 2023-06-05 2023-06-05 8-K
10-Q 2023-03-31 2023-05-04 10-Q
8-K 2023-05-04 2023-05-04 8-K
8-K 2023-04-14 2023-04-17 8-K
8-K 2023-03-23 2023-03-24 8-K
8-K 2023-03-02 2023-03-02 8-K
10-K 2022-12-31 2023-02-23 10-K
8-K 2023-02-23 2023-02-23 8-K
8-K 2023-01-05 2023-01-05 8-K
8-K 2022-11-30 2022-12-01 8-K
8-K 2022-11-12 2022-11-14 8-K
8-K 2022-11-05 2022-11-07 8-K
10-Q 2022-09-30 2022-11-03 10-Q
8-K 2022-11-03 2022-11-03 8-K
8-K 2022-09-16 2022-09-16 8-K
10-Q 2022-06-30 2022-08-04 10-Q
8-K 2022-08-04 2022-08-04 8-K
8-K 2022-06-24 2022-06-24 8-K
8-K 2022-06-14 2022-06-15 8-K
10-Q 2022-03-31 2022-05-05 10-Q
8-K 2022-05-05 2022-05-05 8-K
8-K 2022-04-28 2022-05-03 8-K
8-K 2022-02-28 2022-03-04 8-K
8-K 2022-03-04 2022-03-04 8-K
8-K 2022-02-28 2022-02-28 8-K
10-K 2021-12-31 2022-02-24 10-K
8-K 2022-02-24 2022-02-24 8-K
8-K 2022-02-02 2022-02-03 8-K
8-K 2022-01-06 2022-01-06 8-K
8-K 2021-11-04 2021-11-04 8-K
10-Q 2021-09-30 2021-11-04 10-Q
8-K 2021-08-05 2021-08-05 8-K
10-Q 2021-06-30 2021-08-05 10-Q
8-K 2021-06-29 2021-07-02 8-K
8-K 2021-06-26 2021-06-28 8-K
8-K 2021-06-23 2021-06-24 8-K 062421
8-K 2021-06-21 2021-06-22 8-K
8-K 2021-06-14 2021-06-17 8-K
10-Q 2021-03-31 2021-05-06 10-Q
8-K 2021-05-06 2021-05-06 8-K
8-K 2021-04-09 2021-04-12 8-K GEORGIA KERESTY
10-K 2020-12-31 2021-02-26 10-K
8-K 2021-02-25 2021-02-25 8-K
8-K 2021-01-07 2021-01-07 NTLA_8K_01072021
8-K 2020-12-01 2020-12-02 8-K
8-K 2020-11-09 2020-11-09 8-K
10-Q 2020-09-30 2020-11-05 10-Q
8-K 2020-11-05 2020-11-05 8-K
8-K 2020-10-19 2020-10-19 8-K
8-K 2020-10-02 2020-10-05 8-K
8-K 2020-08-06 2020-08-06 8-K
10-Q 2020-06-30 2020-08-06 10-Q
8-K 2020-06-18 2020-06-19 8-K - ANNUAL MEETING RESULTS
8-K 2020-06-01 2020-06-03 8-K
8-K 2020-05-30 2020-06-01 8-K
10-Q 2020-03-31 2020-05-07 10-Q
8-K 2020-05-07 2020-05-07 8-K
8-K 2020-04-03 2020-04-09 8-K
8-K 2020-03-26 2020-03-26 8-K
8-K 2020-03-12 2020-03-13 8-K ALBANY LEASE
10-K 2019-12-31 2020-02-27 10-K
8-K 2020-02-27 2020-02-27 8-K Q419 EARNINGS RELEASE
8-K 2020-01-09 2020-01-09 8-K FOR PRELIM 2019 RESULTS AND PRESS RELEASE
8-K 2019-12-13 2019-12-16 8-K
8-K 2019-10-31 2019-10-31 8-K
10-Q 2019-09-30 2019-10-31 10-Q
8-K 2019-09-26 2019-09-26 8-K
10-Q 2019-06-30 2019-08-01 10-Q JUNE 2019
8-K 2019-08-01 2019-08-01 8-K
8-K 2019-05-21 2019-05-22 8-K
8-K 2019-05-02 2019-05-02 8-K
10-Q 2019-03-31 2019-05-02 Q119 10-Q
8-K 2019-04-05 2019-04-05 8-K
10-K 2018-12-31 2019-02-27 10-K
8-K 2019-02-27 2019-02-27 8-K
8-K 2019-01-23 2019-01-24 8-K
8-K 2019-01-07 2019-01-07 8-K
8-K 2018-12-03 2018-12-06 Q418 8-K ANNOUNCING EXPANSION OF COLLABORATION WITH NOVARTIS
8-K 2018-10-27 2018-10-31 8-K
10-Q 2018-09-30 2018-10-31 10-Q
8-K 2018-10-29 2018-10-29 8-K
10-Q 2018-06-30 2018-08-01 10-Q
8-K 2018-08-01 2018-08-01 8-K
8-K 2018-07-20 2018-07-20 FORM 8-K
8-K 2018-06-18 2018-06-22 8-K
8-K 2018-05-17 2018-05-21 8-K
8-K 2018-05-01 2018-05-01 FORM 8-K
10-Q 2018-03-31 2018-05-01 10-Q
8-K 2018-04-13 2018-04-17 8-K
10-K 2017-12-31 2018-03-14 10-K
8-K 2018-03-14 2018-03-14 8-K
8-K 2017-12-12 2017-12-18 8-K
8-K 2017-11-01 2017-11-03 FORM 8-K
8-K 2017-10-31 2017-10-31 8-K
10-Q 2017-09-30 2017-10-31 10-Q
8-K 2017-08-30 2017-09-01 8-K
8-K 2017-08-07 2017-08-08 FORM 8-K
8-K 2017-08-01 2017-08-01 FORM 8-K
10-Q 2017-06-30 2017-08-01 10-Q
8-K 2017-07-21 2017-07-25 FORM 8-K
8-K 2017-05-18 2017-05-18 FORM 8-K
10-Q 2017-03-31 2017-05-02 10-Q
8-K 2017-05-02 2017-05-02 8-K
8-K 2017-04-13 2017-04-13 8-K
10-K 2016-12-31 2017-03-14 FORM 10-K
8-K 2017-03-14 2017-03-14 FORM 8-K
8-K 2017-02-15 2017-02-15 FORM 8-K
8-K 2016-12-15 2016-12-16 FORM 8-K
8-K 2016-12-12 2016-12-13 8-K
8-K 2016-11-01 2016-11-04 8-K
8-K 2016-11-01 2016-11-01 8-K
10-Q 2016-09-30 2016-11-01 10-Q
8-K 2016-08-04 2016-08-04 FORM 8-K
10-Q 2016-06-30 2016-08-04 FORM 10-Q
10-Q 2016-03-31 2016-06-03 10-Q
8-K 2016-05-11 2016-05-17 8-K